Advertisement
The Scientist
The Scientist

The Scientist

» drug development and evolution

Most Recent

image: Hacking the Genome

Hacking the Genome

By | June 1, 2012

In pondering genome structure and function, evolutionary geneticist Laurence Hurst has arrived at some unanticipated conclusions about how natural selection has molded our DNA.

6 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

image: Loss of Microtubule Regulator Blocks Sperm Maturation

Loss of Microtubule Regulator Blocks Sperm Maturation

By | May 24, 2012

New research suggests that controlling cytoskeletal dynamics in sperm accessory cells may help regulate male fertility.

0 Comments

image: Revenge of the Weeds

Revenge of the Weeds

By | May 20, 2012

Plant pests are evolving to outsmart common herbicides, costing farmers crops and money.

33 Comments

image: US Drug Approvals Top Canada, Europe

US Drug Approvals Top Canada, Europe

By | May 18, 2012

The FDA approves drugs faster and earlier than regulatory agencies in other countries.

3 Comments

image: Live Slow, Die Old

Live Slow, Die Old

By | May 17, 2012

Ancient bacteria living in deep-sea sediments are alive—but with metabolisms so slow that it’s hard to tell.

13 Comments

image: FDA Eases Sterility Requirements

FDA Eases Sterility Requirements

By | May 16, 2012

The US Food and Drug Administration has relaxed some of the rules governing how companies must test the sterility of materials used to make biologic drugs.

1 Comment

image: How Prawns Lure Prey

How Prawns Lure Prey

By | May 15, 2012

Orange-loving Trinidad guppies are curiously attracted to orange spots on prawn pincers, which may make it easier for the predators to snatch them up.

1 Comment

image: Behavior Brief

Behavior Brief

By | May 15, 2012

A round-up of recent discoveries in behavior research

5 Comments

image: Approving

Approving

By | May 14, 2012

The FDA is on board with a proposal to speed the approval of experimental pharmaceuticals that show big treatment effects early in clinical testing.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement